<DOC>
	<DOCNO>NCT00590096</DOCNO>
	<brief_summary>I-123-MIBG use image patient neuroblastoma , pheochromocytoma neural crest tumor</brief_summary>
	<brief_title>I-123-MIBG Imaging Neuroblastoma Pheochromocytoma</brief_title>
	<detailed_description>Entry criterion -- Histologically document neuroblastoma pheochromocytoma strong suspicion neuroblastoma pheochromocytoma . Exclusion criterion -- Pregnancy Randomization -- None Procedure -- Patients receive dose I-123-MIBG intravenous injection . Images obtain 18-24 hour administration drug 42-48 hour need . SSKI use block thyroid uptake free I-123-iodide</detailed_description>
	<mesh_term>Neuroblastoma</mesh_term>
	<mesh_term>Pheochromocytoma</mesh_term>
	<criteria>Histologically proven neuroblastoma pheochromocytoma strong suspicion neuroblastoma pheochromocytoma Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2007</verification_date>
	<keyword>Neuroblastoma</keyword>
	<keyword>Pheochromocytoma</keyword>
	<keyword>MIBG</keyword>
</DOC>